# Graphene Photothermal Adjuvant Therapy for Mild Corona Virus Disease 2019: A Prospective Randomized Controlled Trial

> **NCT05651815** · NA · UNKNOWN · sponsor: **Southeast University, China** · enrollment: 270 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DEVICE:** Graphene spectrum light wave therapy room

## Key facts

- **NCT ID:** NCT05651815
- **Lead sponsor:** Southeast University, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-22
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-06-30
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2022-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05651815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05651815, "Graphene Photothermal Adjuvant Therapy for Mild Corona Virus Disease 2019: A Prospective Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05651815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*